121. Hypercholesterolemia in two siblings with resistance to thyroid hormones due to disease-causing variant in thyroid hormone receptor (THRB) geneMaja Pajek, Magdalena Avbelj Stefanija, Katarina Trebušak Podkrajšek, Jasna Šuput Omladič, Mojca Žerjav-Tanšek, Tadej Battelino, Urh Grošelj, 2020, original scientific article Keywords: thyroid, resistance to thyroid hormones, RTHβ, thyroid hormone receptor, THRB, hypothyroidism, hypercholesterolemia Full text (file, 480,09 KB) This document has more files! More... |
|
123. Dysregulated expression of arterial microRNAs and their target gene networks in temporal arteries of treatment-naïve patients with giant cell arteritisTadeja Kuret, Katja Lakota, Saša Čučnik, Vesna Jurčić, Oliver Distler, Žiga Rotar, Alojzija Hočevar, Snežna Sodin-Šemrl, Mojca Frank Bertoncelj, 2021, original scientific article Keywords: giant cell arteritis, microRNA, arterial remodelling, microRNA-target genes, toll-like receptor signaling, arterial ultrasound, vision disturbances Full text (file, 1,68 MB) This document has more files! More... |
124. STAT5 as a key protein of erythropoietin signalizationZuzana Tóthová, Jana Tomc, Nataša Debeljak, Peter Solár, 2021, review article Keywords: STAT5, erythropoietin receptor, molecular mechanisms, erythropoietin Full text (file, 872,65 KB) This document has more files! More... |
125. The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodiesTijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan, 2022, original scientific article Keywords: B-cell leukemia and lymphoma, chronic lymphocytic leukemia, prostaglandin EP4 receptor, selective EP4 receptor agonist, monoclonal antibodies, synergistic effects Full text (file, 1,90 MB) This document has more files! More... |
126. Iskanje modulatorjev programirane smrti celic kronične limfocitne levkemijeSanja Nabergoj, 2021, doctoral dissertation Keywords: receptor EP4, prostaglandinski receptorji, receptor NOD2, modelna celična linija MEC-1, protitumorno delovanje, terapija bolnikov, kronična limfocitna levkemija Full text (file, 5,74 MB) |
127. Strukturno podprto načrtovanje, sinteza in vrednotenje novih zaviralcev indolamin 2,3-dioksigenaze in modulatorjev toll-u podobnih receptorjev tipa 7 in 8Ana Dolšak, 2021, doctoral dissertation Keywords: Toll-u podoben receptor 7, Toll-u podoben receptor 8, negativni modulator TLR8, virtualno rešetanje, tvorba C-C vezi, Suzuki reakcija, substituirani pirimidi, imunski sistem, farmacevtska kemija
|
128. Novi radiooznačeni antagonisti holecistokinin-2/gastrinskega receptorjaDoroteja Novak, 2021, doctoral dissertation Keywords: holecistokininski-2/gastrinski receptor, holecistokininski-1 receptor, radionuklidi, analog minigastrina, antagonisti CCK2R, sinteza na trdnem polimernem nosilcu, farmacevtska kemija, disertacije, tumorji Full text (file, 10,95 MB) |
|
130. Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilizationAstrid S. Jørgensen, Viktorija Daugvilaite, Katia De Filippo, Christian Berg, Maša Mavri, Tau Benned-Jensen, Goda Juzenaite, Gertrud Malene Hjortø, Sara Rankin, Jon Våbenø, Mette Marie Rosenkilde, 2021, original scientific article Keywords: stem cells, hematopoietic stem cells, GTP-binding proteins, molecular medicine, receptor pharmacology Full text (file, 2,73 MB) This document has more files! More... |